Kumar Budur, M.D., M.S.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kumar Budur, M.D., M.S.
Harmony Biosciences Holdings, Inc. reported in an 8-K filed May 3, 2024 that Kumar Budur, M.D., M.S. was appointed Executive Vice President and Chief Medical & Scientific Officer, effective May 1, 2024. Kumar Budur, M.D., M.S. has spoken on 2 earnings calls across 1 company, most recently for Harmony Biosciences Holdings, Inc. on May 7, 2026.
“The Board of Directors (the "Board") of Harmony Biosciences Holdings, Inc. (the "Company") appointed Kumar Budur, M.D., M.S., the Company's Chief Medical Officer, to the title of Executive Vice President and Chief Medical & Scientific Officer (the "Appointment"), effective on May 1, 2024 (the "Effective Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-05-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Harmony Biosciences Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- Jeffrey Dayno CEO
- Jeffrey M. Dayno CEO, Board Member
- Jeffrey M. Dayno, M.D. CEO, Board Member
- Jeffrey S. Aronin Chairman
- Glenn Reicin CFO
- Sandip Kapadia CFO
- Susan Drexler CFO
- Peter Anastasiou COO, Board Member
- Eric Motley Board Member
- Linda Szyper Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.